Abstract
The authors sought to evaluate the treatment outcome of children with medulloblastoma at a single institution. Forty-two children were analyzed. Eighty-six percent of the children who received chemotherapy were treated with cisplatin-based chemotherapy. No factors were found to affect outcome significantly. Compared with children treated before 1994 at the same institution, the median survival time was significantly longer (40 vs. 25 months, p =.0003). The authors conclude that some improvement of treatment outcome for children with medulloblastoma seemed to be achieved.
Original language | English |
---|---|
Pages (from-to) | 647-654 |
Number of pages | 8 |
Journal | Pediatric Hematology and Oncology |
Volume | 25 |
Issue number | 7 |
DOIs | |
Publication status | Published - Sept 2008 |
Externally published | Yes |
Keywords
- Children
- Medulloblastoma
- Outcome
- Survival
- Treatment
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology